Covered recipient · General Payments record

HELENE LEE

Allopathic & Osteopathic Physicians Family Medicine

NPI: 1750587408
CMS profile: 170260
Location: ELKTON, MD

General Payments · PY2018–2024

$7,639.76

Reported across 394 records
CMS publication 2026-01-23

Latest program year · PY2024

$1,162.46

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$1,162.46	55

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
ABBVIE INC.	$218.64	9
Acerta Pharma LLC	$183.31	10
Phathom Pharmaceuticals, Inc.	$165.02	3
PFIZER INC.	$151.57	9
Novo Nordisk AS	$72.09	4
Lilly USA, LLC	$50.50	3
Exact Sciences Corporation	$43.66	2
E.R. Squibb & Sons, L.L.C.	$43.09	2
Abbott Laboratories	$39.55	2
GlaxoSmithKline, LLC.	$35.39	2
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$33.03	2
Xeris Pharmaceuticals, Inc.	$29.49	2
Neurocrine BioSciences, Inc.	$24.46	1
Boehringer Ingelheim Pharmaceuticals, Inc.	$24.36	1
Astellas Pharma US Inc	$18.04	1
Merck Sharp & Dohme Corporation	$15.39	1
DEXCOM, INC.	$14.87	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$1,215.17	62
PY2019	$1,128.34	62
PY2020	$1,105.46	61
PY2021	$1,009.54	57
PY2022	$968.91	47
PY2023	$1,049.88	50
PY2024	$1,162.46	55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Abbott Laboratories	$16.52	02/11/2024	Food and Beverage	Undisputed	01/23/2026	1125243583	CMS
Abbott Laboratories	$23.03	09/05/2024	Food and Beverage	Undisputed	01/23/2026	1125243587	CMS
ABBVIE INC.	$7.86	01/22/2024	Food and Beverage	Undisputed	01/23/2026	1104152244	CMS
ABBVIE INC.	$10.63	01/26/2024	Food and Beverage	Undisputed	01/23/2026	1104152246	CMS
ABBVIE INC.	$123.08	02/09/2024	Food and Beverage	Undisputed	01/23/2026	1104152248	CMS
ABBVIE INC.	$20.38	02/22/2024	Food and Beverage	Undisputed	01/23/2026	1104152250	CMS
ABBVIE INC.	$12.20	04/19/2024	Food and Beverage	Undisputed	01/23/2026	1104152252	CMS
ABBVIE INC.	$2.17	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1104152254	CMS
ABBVIE INC.	$23.42	05/30/2024	Food and Beverage	Undisputed	01/23/2026	1104152256	CMS
ABBVIE INC.	$5.25	06/26/2024	Food and Beverage	Undisputed	01/23/2026	1104152258	CMS
ABBVIE INC.	$13.65	07/25/2024	Food and Beverage	Undisputed	01/23/2026	1104152260	CMS
Astellas Pharma US Inc	$18.04	09/24/2024	Food and Beverage	Undisputed	01/23/2026	1139403119	CMS
AstraZeneca Pharmaceuticals LP	$14.92	01/08/2024	Food and Beverage	Undisputed	01/23/2026	1105760085	CMS
AstraZeneca Pharmaceuticals LP	$18.27	02/13/2024	Food and Beverage	Undisputed	01/23/2026	1105677953	CMS
AstraZeneca Pharmaceuticals LP	$25.59	03/01/2024	Food and Beverage	Undisputed	01/23/2026	1104573072	CMS
AstraZeneca Pharmaceuticals LP	$16.99	04/18/2024	Food and Beverage	Undisputed	01/23/2026	1104388953	CMS
AstraZeneca Pharmaceuticals LP	$13.54	05/09/2024	Food and Beverage	Undisputed	01/23/2026	1105446923	CMS
AstraZeneca Pharmaceuticals LP	$17.45	06/10/2024	Food and Beverage	Undisputed	01/23/2026	1104735919	CMS
AstraZeneca Pharmaceuticals LP	$19.66	07/12/2024	Food and Beverage	Undisputed	01/23/2026	1105609427	CMS
AstraZeneca Pharmaceuticals LP	$19.95	08/15/2024	Food and Beverage	Undisputed	01/23/2026	1104274155	CMS
AstraZeneca Pharmaceuticals LP	$17.18	08/26/2024	Food and Beverage	Undisputed	01/23/2026	1105622061	CMS
AstraZeneca Pharmaceuticals LP	$19.76	10/24/2024	Food and Beverage	Undisputed	01/23/2026	1104488990	CMS
Boehringer Ingelheim Pharmaceuticals, Inc.	$24.36	10/21/2024	Food and Beverage	Undisputed	01/23/2026	1118139970	CMS
Dexcom, Inc.	$14.87	07/15/2024	Food and Beverage	Undisputed	01/23/2026	1153303565	CMS
E.R. Squibb & Sons, L.L.C.	$22.83	04/11/2024	Food and Beverage	Undisputed	01/23/2026	1101562942	CMS
E.R. Squibb & Sons, L.L.C.	$20.26	11/25/2024	Food and Beverage	Undisputed	01/23/2026	1101563069	CMS
Exact Sciences Corporation	$27.49	04/22/2024	Food and Beverage	Undisputed	01/23/2026	1114752102	CMS
Exact Sciences Corporation	$16.17	09/09/2024	Food and Beverage	Undisputed	01/23/2026	1114752107	CMS
GlaxoSmithKline, LLC.	$13.69	03/25/2024	Food and Beverage	Undisputed	01/23/2026	1116736700	CMS
GlaxoSmithKline, LLC.	$21.70	04/30/2024	Food and Beverage	Undisputed	01/23/2026	1116448847	CMS
Lilly USA, LLC	$16.67	02/26/2024	Food and Beverage	Undisputed	01/23/2026	1135024426	CMS
Lilly USA, LLC	$18.39	03/12/2024	Food and Beverage	Undisputed	01/23/2026	1135002160	CMS
Lilly USA, LLC	$15.44	08/08/2024	Food and Beverage	Undisputed	01/23/2026	1135002162	CMS
Merck Sharp & Dohme LLC	$15.39	07/29/2024	Food and Beverage	Undisputed	01/23/2026	1141635167	CMS
Neurocrine Biosciences, Inc.	$24.46	06/20/2024	Food and Beverage	Undisputed	01/23/2026	1150841606	CMS
Novo Nordisk Inc	$21.30	01/29/2024	Food and Beverage	Undisputed	01/23/2026	1096619370	CMS
Novo Nordisk Inc	$16.84	02/15/2024	Food and Beverage	Undisputed	01/23/2026	1097082814	CMS
Novo Nordisk Inc	$15.84	08/29/2024	Food and Beverage	Undisputed	01/23/2026	1096577601	CMS
Novo Nordisk Inc	$18.11	10/07/2024	Food and Beverage	Undisputed	01/23/2026	1097817288	CMS
PFIZER INC.	$21.29	03/04/2024	Food and Beverage	Undisputed	01/23/2026	1131141592	CMS
PFIZER INC.	$15.78	04/08/2024	Food and Beverage	Undisputed	01/23/2026	1131285255	CMS
PFIZER INC.	$9.42	06/24/2024	Food and Beverage	Undisputed	01/23/2026	1130920357	CMS
PFIZER INC.	$13.65	07/22/2024	Food and Beverage	Undisputed	01/23/2026	1131769826	CMS
PFIZER INC.	$7.03	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1130934411	CMS
PFIZER INC.	$20.74	10/17/2024	Food and Beverage	Undisputed	01/23/2026	1132080878	CMS
PFIZER INC.	$20.43	10/31/2024	Food and Beverage	Undisputed	01/23/2026	1132114197	CMS
PFIZER INC.	$15.85	11/04/2024	Food and Beverage	Undisputed	01/23/2026	1132098289	CMS
PFIZER INC.	$27.38	12/12/2024	Food and Beverage	Undisputed	01/23/2026	1131121346	CMS
Phathom Pharmaceuticals, Inc.	$21.03	03/18/2024	Food and Beverage	Undisputed	01/23/2026	1151087309	CMS
Phathom Pharmaceuticals, Inc.	$125.00	09/13/2024	Food and Beverage	Undisputed	01/23/2026	1151087311	CMS
Phathom Pharmaceuticals, Inc.	$18.99	09/30/2024	Food and Beverage	Undisputed	01/23/2026	1151087313	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$16.82	11/19/2024	Food and Beverage	Undisputed	01/23/2026	1153470453	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$16.21	12/10/2024	Food and Beverage	Undisputed	01/23/2026	1153683377	CMS
Xeris Pharmaceuticals, Inc.	$16.30	04/01/2024	Food and Beverage	Undisputed	01/23/2026	1144596342	CMS
Xeris Pharmaceuticals, Inc.	$13.19	07/08/2024	Food and Beverage	Undisputed	01/23/2026	1144596344	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.